Business ❯ Pharmaceuticals

AstraZeneca

Financial Performance Investment Vaccine Development Growth Strategy New Medicines Expansion Investments Technology Advancements Research and Development Investment Decisions Acquisition Merger Vaccine Work Costs Products Vaccine Withdrawal US Market Production Corporate Strategy Market Strategy Innovation Revenue Growth Legal Settlements Stock Market

Enhertu Improves Progression‑Free Survival in Phase 3 HER2‑Mutant Lung Cancer Trial

The topline result could lead AstraZeneca and Daiichi Sankyo to seek regulatory approval to use the drug as first‑line therapy.

Texas Wins Nearly $34 Million From AstraZeneca Over Alleged Medicaid Kickbacks

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion